1. Introduction {#sec1}
===============

Drug addiction is a chronic relapsing disorder, with a complex etiology and a limited number of approved pharmacotherapeutics to combat it. Additionally, stress can exacerbate the reinforcing properties of multiple drugs of abuse, leading to an increased likelihood for individuals with stress-related disorders, such as anxiety, to develop substance use disorders (SUDs). The experience of adverse events early in life, defined broadly as early life stress (ELS), is a major risk factor for the emergence of SUDs. Especially troubling is the relationship between ELS, the development of SUDs during adolescence, and the risk to relapse after a period of abstinence ([@bib69]; [@bib152]). Given that initial experimentation with recreational drugs during adolescence has been linked to problematic drug use later in life ([@bib79]; [@bib165]), it is especially concerning for a SUD to develop at such a young age. Furthermore, that chronic drug use may dramatically alter the normative neurobiological development that occurs in adolescence is also disconcerting. Finally, women who have experienced ELS tend to have worse drug use outcomes as a function of ELS in comparison to men.

The impetus for this review is the fact that the neurobiological mechanisms underlying this increased vulnerability to adolescent SUDs following a history of ELS remain unclear. However recent research suggests that deficits in emotional regulation as a result of neurobiological alterations that accompany ELS may be a mechanism of interest. Deficits in emotional regulation also accompany anxiety and other stress-related disorders that are not only co-morbid with SUDs but also more prevalent in women ([@bib67]; [@bib69]; [@bib150]). Moreover, a hyperactive stress-response system as a consequence of ELS may drive alterations in reward-related circuitry, creating a primed neurobiological system that may be uniquely sensitive to the reinforcing effects of drugs of abuse and to relapse.

These questions are very difficult to address in human populations, as they require prospective, longitudinal studies beginning in early childhood. Thus, we turn to animal models of ELS, given that stress also increases vulnerability to drug self-administration in animal models and is similarly reflected in increases in anxiety and emotionality ([@bib28]; [@bib39]; [@bib111]; [@bib114]). Given that ELS results in alterations in neural circuits involved in reward and inhibitory control of behavior in adult humans ([@bib21]; [@bib51]), examining the functional consequences of ELS on neurobiological targets using NHP models is critical due to the high homology of these brain regions with humans. We will also explore the possibility that alterations in areas of the brain relevant to drug use happen in parallel to disruptions in stress and emotional regulatory systems occurring during adolescence.

The purpose of this review is to examine the literature linking the occurrence of ELS and adolescent SUDs in NHP models of ELS and drug abuse. In doing so, our goals are threefold: 1) to elucidate potential mechanisms linking a history of ELS to adolescent SUD, 2) to highlight sex differences where they occur, despite the general paucity of studies examining sex as a biological variable in models of ELS and drug abuse, and 3) given the scarce literature, to encourage researchers working with NHP models of ELS or drug abuse to collaborate across laboratories to bridge both scientific fields. To accomplish these goals, we will start by examining the current landscape of adolescent drug use in the United States as well as the clinical literature reporting ELS as a major risk for the development of SUDs later in life. We will then highlight the critical importance of NHP models of ELS and drug abuse as an opportunity to expand on what is currently known in the rodent literature as a translational bridge to humans. Finally, we will touch on the few studies explicitly studying NHP models of ELS that have also examined the contribution of ELS to adolescent drug self-administration.

2. Current adolescent drug use trends {#sec2}
=====================================

Adolescence is widely viewed as the developmental stage whereby drug use is initiated. Based on the findings of the latest Monitoring the Future national survey on drug use in 2017 ([@bib73]) alcohol remained the most used substance in high-school teenagers (8th, 10th, and 12th grades), with around 60% of teenagers reporting that they had consumed alcohol ever and 20% consuming alcohol by 8th grade. Additionally, the annual prevalence of marijuana use in teenagers also rose in 2017, reaching approximately 23.9% combined across school grades, and annual prevalence of cocaine use increased marginally to approximately 1.6% combined across school grades. Interestingly, the same study documented specific sex differences in adolescent drug use as well as period-specific drug use that differed as a function of sex (see [Table 1](#tbl1){ref-type="table"}; [@bib73]). For example, although boys start using alcohol earlier than girls, the opposite is true for initiation of other drug classes, such as amphetamines, sedatives and inhalants. These findings highlight that both the adolescent stage (early versus late) and the drug used are necessary variables to consider when examining unique susceptibilities of male and female adolescents to drug use.Table 1Early versus late adolescent alcohol, tobacco, amphetamine, sedative, and inhalant drug use. X indicates greater usage. -- Indicates no difference between males and females.Table 1AgeDrugMalesFemales8^th^ Grade (Early Adolescence)AlcoholxTobacco----AmphetaminesxSedativesxInhalantsx12^th^ Grade (Late Adolescence)AlcoholxTobaccoxAmphetamines----Sedatives----Inhalants----

These sex and age-specific differences in drug use may have consequences for later drug use in life. In fact, considerable sex differences are evident in the progression from initiation of drug use (or experimentation) to the onset of drug dependence, a phenomenon termed "telescoping," ([@bib43]; [@bib53]). In a study examining substance-dependent men and women, women showed higher rates of telescoping for opiates, marijuana, and alcohol, and also reported experiencing greater psychiatric, medical, and social consequences of their dependence in comparison to men ([@bib53]). Importantly, there were no differences in initiation of regular drug use in this study, corroborating other reports that sex differences in SUDs typically do not emerge until late adolescence or early adulthood (for a review, see [@bib90]). That there are no sex differences in the onset of adolescent SUD until late adolescence suggests important neurobiological, hormonal, social, and cultural factors that may modulate period-specific differences in drug use. Of the factors that may be critical in determining susceptibility to drug abuse, this review will focus on how early adverse experiences (i.e. ELS) may be a risk factor in both the onset and severity of drug use.

3. ELS as a risk factor in the etiology of drug abuse {#sec3}
=====================================================

While many genetic, social, and environmental factors are critical in determining an individual\'s risk to SUDs, the occurrence of ELS represents a significant vulnerability factor in the etiology of addiction ([@bib31]; [@bib67]; [@bib68]; [@bib151]). ELS can encompass a wide range of adverse experiences, including childhood maltreatment and exposure to trauma, the effects of which are robust and long lasting (for a review, see [@bib31]). SUD outcomes show dramatic differences based on the sex of the individual as well as the severity and type of childhood maltreatment experienced (i.e. physical, emotional, or sexual abuse; physical or emotional neglect). For example, greater severity of emotional abuse, sexual abuse, and overall maltreatment predicted a younger age of first alcohol use in women, whereas only severity of emotional abuse predicted age of first alcohol use in men ([@bib67]). In the same study, severity of emotional abuse, emotional neglect, and overall maltreatment predicted lifetime substance use severity in women, whereas emotional abuse severity predicted lifetime substance use severity in men. Interestingly, age of first alcohol use predicted age of first cocaine use in men and women, but only predicted age at which cocaine was used regularly in women. Furthermore, studies have shown that greater severity of childhood emotional abuse is associated with an increased risk of relapse and number of days where cocaine is used during relapse in women but not men ([@bib68]). Collectively, these data suggest that the occurrence of ELS leads to worse outcomes in women in comparison to men, including severity of drug use as well as propensity to relapse following abstinence. They also demonstrate that emotional abuse and neglect may be better predictors for measurements of drug addiction than physical abuse, suggesting specific forms of ELS may better predict different psychopathologies and that these effects vary based on the sex of the victim.

4. The need for translational preclinical models of human disease: WHY NHPs? {#sec4}
============================================================================

4.1. Development of socioemotional behavior {#sec4.1}
-------------------------------------------

NHPs provide valuable translational animal models of ELS in relation to risk for drug abuse, based on their close social, behavioral, and neurobiological similarity to humans ([@bib65]; [@bib64]; [@bib135]; [@bib134]). NHP models of ELS can also employ experimental manipulations not feasible in humans, and allow for in-depth examinations of developmental psychopathology ([@bib35]). Monkeys, including rhesus macaques, demonstrate cortical complexity and phylogenetic similarity to humans ([@bib7]; [@bib26]; [@bib124]; [@bib158]). This includes the prefrontal cortex (PFC), which has a high degree of homology between humans and NHP species, in comparison with rodents ([@bib33]; [@bib45]; [@bib117]; [@bib122], [@bib121]; [@bib120]). NHPs also have additional advantages when modeling aspects of stress neuroendocrine function (e.g. hypothalamic-pituitary-adrenal (HPA) axis) due to differences between rodent and primate brain stress systems, which is particularly important in relation to ELS and risk for drug addiction ([@bib118]; [@bib123]; [@bib141]; [@bib140]; [@bib134]). Brain development and maturation in NHPs also follows trajectories and anatomical patterns comparable to humans, albeit monkeys are precocious at birth and develop at about 4 times the speed of human children ([@bib50]; [@bib66]; [@bib81]).

Like humans, NHPs have an extended postnatal period during which maternal caregiving is critical for physiological growth, socioemotional maturation, and neurodevelopment sensitivity to environmental experiences. Rhesus monkeys, in particular, have been a species widely used to study the impact of social environment because they experience complex social relationships and form strong social alliances and bonds ([@bib57]; [@bib156]), beginning with the strong and enduring mother-infant bond, similar to that seen in humans ([@bib15]; [@bib55]). The mother provides nourishment, protection, and social lessons while also regulating the infant\'s fear and stress responses ([@bib22]; [@bib44]; [@bib52]; [@bib56]; [@bib135]; [@bib137]). Even as the offspring becomes more independent and interact more with their peers and other troop members they will maintain contact with their mother, particularly for comfort and support during stressful events ([@bib57]; [@bib156]). In doing so, the mother still exerts a buffering effect on her offspring\'s stress responses, protecting them from the deleterious effects of stress on neurobiological and neuroendocrine development ([@bib137]). Altogether, this evidence demonstrates that competent maternal care is necessary for the proper development of emotional behavior and stress neuroendocrine function (including HPA axis), and predicts better emotional and stress regulation later in life ([@bib134]; [@bib136]).

4.2. Development of neurobiological systems regulating stres/emotion and reward {#sec4.2}
-------------------------------------------------------------------------------

Areas of the brain related to emotional regulation and inhibitory control of behavior, such as the PFC, follow a region-specific developmental progression ([@bib92]; [@bib101]). These higher-order association cortices reach cortical maturation later in life in comparison to lower-order cortices, while white matter tracts allow these regions to be functionally connected along a similar maturational pattern ([@bib37]; [@bib36]; [@bib40]; [@bib125]). This developmental pattern suggests that the more frontal regions such as the PFC that have a protracted or prolonged maturation period may be the most impacted by ELS ([@bib2]; [@bib25]). In addition to their vulnerability to ELS due to the protracted development of these regions, these brain areas play a critical role in modulating stress and emotional reactivity, with the PFC exerting critical top-down control of amygdala activation in response to threats and stressors ([@bib82]). Higher emotional reactivity and risky behavior that is typical of adolescence may be occurring because this time period occurs in the interim between earlier/faster maturation of subcortical regions and the protracted development of cortical regulatory regions such as the PFC ([@bib153]). Therefore, the increased sensitivity of these regions to ELS during adolescence may lead to experience-based alterations in PFC-amygdala functional connectivity and contribute to early initiation of drug abuse ([@bib116]).

In addition to the development of top-down inhibitory control of the amygdala by the PFC, there is also considerable remodeling within the PFC itself that occurs until early adulthood, but particularly during adolescence ([@bib37]; [@bib40]; [@bib148]; [@bib154]). Dopamine (DA) innervation to the medial PFC (mPFC) increases throughout this developmental period with marked refinement and organization that occurs during adolescence ([@bib11]; [@bib78]; [@bib102]; [@bib115]; [@bib131]). For example, synapses with these DA afferents in the PFC, especially with GABAergic interneurons ([@bib12]; [@bib146]; [@bib161]) become more sensitive to modulation by DA ([@bib41]; [@bib143]; [@bib167]). Additionally, DA 1 (D1) receptor expression increases during adolescence, compared to the juvenile period and adulthood, modulates glutamatergic projections from PFC to subcortical regions like the nucleus accumbens (NAc), which plays a prominent role in drug-seeking behaviors ([@bib76]; [@bib144]). Altogether, the important developmental changes in DA innervation and receptors in the PFC and NAc during adolescence can explain, at least in part, the unique vulnerability of these systems to drug exposure, which can result in enduring behavioral effects ([@bib126]).

4.3. Development and dysregulation of neuroendocrine stress systems {#sec4.3}
-------------------------------------------------------------------

Additional outcomes of ELS associated with drug abuse include alterations in neuroendocrine stress response systems such as the HPA axis (for a review, see [@bib31]). ELS can result in the development of a hyperreactive HPA axis through different mechanisms, including: (1) a hyperactive amygdala that increases stress neuroendocrine responses through downstream projections to the HPA axis and sympathetic systems, and (2) local changes in HPA axis function. These local changes include impaired glucocorticoid negative feedback as a result of downregulation/desensitization of glucocorticoid receptors (GRs) in areas of the brain such as the paraventricular nucleus (PVN), pituitary, hippocampus, and the PFC ([@bib64]; [@bib135]; [@bib134]). Altogether, this can result in persistently elevated levels of cortisol and activation of the stress neuropeptide corticotropin-releasing factor (CRF) within the NAc ([@bib85]; [@bib84]; [@bib87]; [@bib89]; [@bib91]) which can lead to altered dopaminergic transmission in reward circuits linked to stress-induced increases in the reinforcing properties of drugs of abuse as measured by self-administration ([@bib77]).

Stressful events increase the acquisition of a number of drugs of abuse ([@bib39]; [@bib46]; [@bib88]; [@bib119]), and chronic stress has long-term effects on the dopaminergic system that may impose an increased risk for drug addiction ([@bib31]). Specifically, DA regulates motivational, emotional, and reinforced behavior through mesolimbic dopaminergic projections from the ventral tegmental area (VTA) to the NAc and PFC. Stress-induced increases in the reinforcing properties of drugs of abuse may be explained by the fact that stress and drugs of abuse (such as psychostimulants) increase extracellular DA levels in the NAc on their own. Repeated stress exposure increases both the magnitude and duration of NAc DA release in response to psychostimulants ([@bib75]). This is mediated in part by DA 2 (D2) receptor upregulated-mediated effects in synaptic function ([@bib149]) and by glucocorticoid action on GRs in neurons with DA afferents ([@bib1]). These data suggest that elevations in glucocorticoids and alterations in the mesolimbic DA system constitute two pathways whereby chronic stress primes neurobiological systems to be more sensitive to the reinforcing effects of drugs of abuse. This is particularly true for the ventral striatum (NAc) as well as the PFC, which provides top-down control in the execution of inhibitory control, decision-making, and receives innervation from both the VTA and ventral striatum (for reviews, see [@bib87]; [@bib162]).

Stress and emotional regulatory circuits, such as the extended amygdala (which includes the central nucleus of the amygdala (CeA), bed nucleus of the stria terminalis (BNST), and the shell of the NAc) have strong connections to the ventral striatum, and these connections may play a prominent role in stress-induced increases in the reinforcing effects of drugs ([@bib86]). Thus, chronic stress and drug self-administration both increase activation of the HPA axis, leading to persistent elevations of circulating cortisol and activation of the stress neuropeptide and neuromodulator CRF within the NAc and the extended amygdala ([@bib85]; [@bib84]; [@bib87]; [@bib89]; [@bib91]). Recent findings from an ELS rodent model suggest that increased CRF in NAc could also originate in increased CRF projections from the CeA, where CRF is overexpressed in ELS animals ([@bib14]). The same study also shows alterations in amygdala connectivity with the mPFC that affect top-down control of anxiety/fear responses. Altogether, the studies summarized here highlight that connections between the amygdala, PFC, and ventral striatum constitute a pathophysiological circuit by which ELS can impact the development of both stress and reward systems that modulate the effects of drugs of abuse.

5. NHP models of ELS and drug abuse {#sec5}
===================================

5.1. NHP models of ELS {#sec5.1}
----------------------

The development and utilization of NHP models of ELS has substantially increased our understanding of both healthy and pathological disease states. While this is not an exhaustive literature review of NHP models of ELS, this section covers several relevant models of ELS that have also been used to examine its link to drug use later in life. Sex differences will be discussed within each model if data are available, as well as the potential neurobiological, neuroendocrine, and/or behavioral consequences of each specific model of ELS. It is important to point out that there is a dearth of literature on NHP models of ELS and drug use in adolescence.

*Peer-rearing versus Maternal Rearing*: One of the most devastating ELS experiences is the disruption of the mother-infant bond. Decades of research have demonstrated the powerful role of the mother on primate infant development beyond nutrition, protection, and comfort. Specifically, they have examined how alterations in the early social environment can lead to the development of different psychopathologies (for extensive reviews, see [@bib49]; [@bib63]; [@bib135]; [@bib145]; [@bib157]). From these pioneering studies, one specific form of ELS (peer-rearing; PR) has been used extensively to examine multiple consequences of ELS. In PR procedures, neonates are removed from their mothers at birth, cared for in a nursery for 30 days postnatal, and then placed in a cage with age-matched peers for 6 months, and they are compared with infants maternally-reared (MR) during the first 6 months of their life. In both groups, animals do not have access to other adults. At approximately 7 months, MR animals are removed from their mothers and placed with PR animals, so that all animals are treated identically thereafter. In this model, PR animals consistently show elevated levels of plasma cortisol in comparison to MR animals ([@bib32]; [@bib54]; [@bib63]). As a result of this early adversity, decreases in cerebrospinal fluid (CSF) concentrations of the serotonin (5HT) metabolite 5-Hydroxyindoleacetic acid (5-HIAA) have been reported in PR animals, suggesting lower brain 5HT function (turnover), an effect that has been widely associated with higher incidence of risk-taking and anxiety.

*Repeated Maternal Separation*: Repeated maternal separation (RMS) is another model of ELS which involves the intermittent and unpredictable separation of the mother from the infant, who remains in the social group, for periods ranging from 0.5 to 6 h. During weaning (3--6 months postpartum), these experimental manipulations have profound effects on the mother-infant bond, the tempo of social development, anxiety, and altered HPA axis function ([@bib138]). Maternal separation at earlier ages (less than 3 months of age) causes even more severe developmental effects ([@bib116]). RMS also results in alterations in brain function, such that left dorsolateral PFC activation is blunted and a compensatory increase in right dorsolateral and right ventral temporal/occipital lobe is observed during separations ([@bib63]; [@bib127]). Regarding sex differences in vulnerability to this type of ELS, female infants seem more vulnerable than males both in terms of their higher cortisol responses to brief maternal separations and the long-term impact on diurnal cortisol rhythms ([@bib138]).

*Social Subordination*: Social subordination represents another translational model of ELS-induced risk for substance abuse. Because rhesus monkeys live in complex social troops with matrilineal hierarchies, an animal\'s place within that hierarchy determines its access to many resources ([@bib13]; [@bib63]; [@bib133]). This hierarchy is strictly maintained through the use of aggression from dominant to subordinate animals, and as a result of these unprovoked and unpredictable agonistic interactions, subordinate animals show greater instances of stress and anxiety. Because infants acquire the relative rank of their mothers and families within the social group, infants from subordinate mothers are subject to significant pressure, aggression, and stress as a result of their social status beginning early in life ([@bib58]; [@bib63]; [@bib133]). Consequences of social subordination include exposure to higher rates of aggression, lower rates of affiliation ([@bib63]; [@bib109]), and chronic hyperactivity of the HPA axis demonstrated by hypercortisolemia and impaired glucocorticoid negative feedback ([@bib63]; [@bib71]; [@bib80]; [@bib109]) that is evident during juvenile and prepubertal developmental stages ([@bib59]).

*Infant Maltreatment*: Finally, our laboratory has utilized an infant maltreatment model of ELS, which displays high translational relevance to humans. Infant maltreatment is not unique to humans, as it is reported to spontaneously occur in NHP species, such as macaques, baboons and marmosets, both in wild and captive populations ([@bib18]; [@bib19]; [@bib72]; [@bib100]; [@bib96]; [@bib160]; [@bib159]). In macaques, infant maltreatment by the mother is operationalized by two, often comorbid, behaviors: physical abuse and rejection, for which the highest rates occur in the first two to three months of life ([@bib96]; [@bib97]; [@bib104]; [@bib103]). Physical abuse includes aberrant, violent behaviors that the mother exhibits towards the infant, leading to pain and distress in the infant ([@bib62]; [@bib96]; [@bib104]; [@bib103]). Although infant rejection is a developmentally typical behavior around the time of weaning, the mother pushing away the infant when it tries to make contact with her is abnormal earlier in life and results in similar distress behaviors as abuse ([@bib96]; [@bib104]). In addition to intense infant distress, these adverse experiences also lead to elevations in stress hormones ([@bib30]; [@bib61]; [@bib60]), long-term HPA axis hyperreactivity ([@bib83]; [@bib136]), increased emotional reactivity ([@bib139]), decreased brain DA and 5HT function that is associated with increased anxiety ([@bib98], [@bib99]), and alterations in the structure and connectivity of PFC-amygdala tracts important for emotional/stress regulation and reward processes ([@bib61], [@bib59], [@bib62]). Sex differences are also present well before puberty, with females showing heightened vulnerability to emotional and stress alterations in comparison to males ([@bib30]).

5.2. NHP models of adolescent drug abuse {#sec5.2}
----------------------------------------

NHPs represent an invaluable tool in examining the progression of drug use from initiation to dependence, as well as for carefully dissecting how other variables may play a role in the etiology of drug dependence. Through the use of operant schedules of reinforcement, NHPs are trained to perform a set of response requirements that, once met, results in the presentation of a reinforcing stimulus ([@bib16]; [@bib23]). Validated extensively, drug self-administration has been widely characterized and regarded as the most translationally-relevant behavioral model to examine multiple facets of human drug use and abuse such as initiation, maintenance, escalation, and relapse of drug-taking (for extensive reviews, see [@bib5]; [@bib6]; [@bib47]; [@bib65]; [@bib107]). As demonstrated in the clinical literature, the ability to thoroughly examine the developmental etiology of drug dependence requires a longitudinal approach, whereby initiation of drug use and its progression to dependence can be studied over a significant period of time. The use of drug self-administration procedures also provides excellent control over parametric conditions and variables (such as sex, age, and early environmental history) that are known to influence not only drug-taking ([@bib166]), but that may also be inherently critical to our understanding of potential mechanisms responsible for individual susceptibility to the reinforcing effects of drugs.

Sex differences in NHP models of drug self-administration often depend on the drug examined, the schedule of reinforcement used, as well as the phase of drug self-administration examined (i.e., acquisition versus maintenance; for a review, see [@bib132]). For example, while no sex differences were reported in the acquisition of ethanol self-administration in adult rhesus macaques ([@bib42]), females do show a greater frequency of alcohol intake during maintenance conditions in comparison to males ([@bib74]). Similarly, adult female rhesus macaques show higher break points for cocaine across multiple doses in comparison to males ([@bib106]). These data suggest that both the drug and phase of drug self-administration are critical variables in examining potential sex differences in drug-maintained responding. Unfortunately, there is a general lack of studies examining adolescent self-administration in NHPs. Furthermore, there are no studies to the authors' knowledge that directly compare adolescent versus adult self-administration in NHPs. While a review of rodent models of adolescent self-administration is beyond the scope of this review, multiple studies have demonstrated age differences in drug-reinforced behavior using rodents. Specifically, adolescent rats self-administer more nicotine ([@bib93]; [@bib94]), escalate methamphetamine self-administration ([@bib3]), acquire amphetamine self-administration faster and show greater amphetamine intake ([@bib147]), and consume greater amounts of ethanol ([@bib29]) in comparison to adults. To date, the vast majority of adolescent rodent self-administration work has suggested that females show a unique susceptibility to psychostimulants as well as other drugs of abuse, and that measures of adolescent drug self-administration typically exceed adult drug self-administration. These data demonstrate the utility and versatility of the drug self-administration procedure, and reveal the ability to adequately examine factors that contribute to drug abuse liability, such as age and sex.

5.3. NHP models of ELS as a predictive risk factor in the etiology of drug abuse {#sec5.3}
--------------------------------------------------------------------------------

While this section will focus on NHP models of ELS that have examined risk to drug self-administration, we were able to find only one study that met the three criteria as originally set out for this review. Those criteria included 1) the utilization of a NHP model of ELS, 2) adolescent drug self-administration, and 3) the utilization of both male and female subjects. Therefore, the following section will cover NHP models of ELS that examine risk to drug self-administration in adulthood, while reporting on sex differences where available.

The contribution of ELS to susceptibility to the reinforcing effects of drugs in rhesus monkeys has been investigated in several studies ([@bib10]; [@bib32]; [@bib54]; [@bib142]). The focus of these studies was on alcohol consumption and only one explicitly examined differences between adolescent males and females ([@bib32]), highlighting the general paucity of data surrounding NHP models of ELS, sex, and adolescent vulnerability to drug intake, despite their high translational value. Utilizing a well-characterized PR model of early adversity, infant rhesus monkeys were subjected to either PR or normal MR early in life ([@bib54]). In late adolescence (50 months), animals were given access to a choice of an aspartame-sweetened 7% ethanol solution as well as an aspartame-sweetened non-caloric vehicle for 1 h a day, 4 days a week, for 8 consecutive weeks. Alcohol consumption was measured at baseline (two-week home cage period with their cage-mates), as well as during social separations (four 4-day periods whereby animals were isolated from their cage-mates and characterized as a period of intense stress). At baseline and during the recovery period following separation, PR animals consumed alcohol at nearly double the rate in comparison to MR animals. During social separations, MR animals significantly increased their alcohol consumption in comparison to their baseline levels and to levels similar to the PR animals. Interestingly, PR animals did not show significantly different consumption compared to their baseline during these separation phases, nor did significant differences in consumption between MR and PR animals emerge following separations. In both rearing conditions, alcohol consumption resulted in blood-alcohol (BAC) levels sufficient to produce intoxication. Finally, plasma cortisol was higher in PR animals at baseline as well as during separation in comparison to MR animals, and this positively correlated with alcohol consumption during the separation period in all animals regardless of rearing condition.

The findings described above were replicated using a near identical procedure where both PR and MR animals underwent 4 sequential weeks of a 4-day social separation, starting at 6 months of age ([@bib32]). The same animals were tested for voluntary alcohol intake over several weeks during young adulthood. Social separation increased plasma cortisol levels in all infants, though PR infants showed a larger increase than MR infants. Cortisol response to social separation in infancy positively correlated with alcohol consumption in adulthood, such that animals with higher cortisol responses to the separation procedure consumed more alcohol as adults independent of rearing condition. Finally, male and PR animals consumed significantly more alcohol than female and MR animals, respectively ([@bib32]).

Low levels of brain 5HT have been consistently reported in PR macaques which, as has previously been demonstrated in humans, are associated with impaired impulse control, and this hypo-serotonergic tone was also related to greater voluntary alcohol consumption when animals were given free access to alcohol ([@bib8], [@bib9], [@bib10]; [@bib105]). Interestingly, decreased 5HT neurotransmission has also been linked to genetic variants in the 5HT transporter (5HTT) gene promoter region of rhesus monkeys (rh5-HTTLPR) that reduce its expression, so that adolescent and young macaques that are carriers of the short (s) allele (which results in decreased 5HTT mRNA levels), show higher levels of alcohol preference than animals homozygous for the long (l) allele (l/l) ([@bib8], [@bib9]; [@bib8], [@bib9], [@bib10]; [@bib95]). Finally, while PR females did not show differences in alcohol consumption during initial exposures in comparison to MR subjects, they did show marked increases in their levels of alcohol consumption through successive exposure to alcohol than seen in males. These two studies demonstrate that early adversity in the form of PR was related to greater vulnerability to alcohol consumption in late adolescence/early adulthood particularly in response to stress in comparison to MR animals, and females showed greater increases in their alcohol consumption with successive exposures in comparison to males.

As seen throughout this section very limited data exist on the effects of PR and RMS on drug self-administration in NHPs. However, one study examined the effects of RMS on sensitivity to the reinforcing effects of cocaine in a group of adult females that experienced RMS as infants ([@bib24]). At approximately 5--6 years of age both control and RMS animals were examined under a second-order schedule of reinforcement, where completion of a fixed-ratio (FR) requirement resulted in the presentation of a light stimulus and a drug infusion was delivered upon completing the first FR 20 lever responses after a fixed interval of 10 min had elapsed. Interestingly, maternally separated animals showed significantly lower response rates in comparison to control animals during acquisition as well as maintenance of self-administration, suggesting that maternally separated animals were less sensitive to the reinforcing effects of cocaine. The authors suggested that lower response rates may be related to decreases in motivation to obtain a highly reinforcing stimulus in the maternally separated animals, especially in light of the fact that response rates across a full dose-response function in these animals resulted in significantly lower response rates in comparison to control animals at almost all doses. These findings raise the possibility that ELS, and specifically RMS, may result in a decreased sensitivity to the reinforcing effects of psychostimulants.

The effects of social subordination on risk for drug abuse have been explored in laboratory environments using cocaine self-administration, although it is important to note that the impact of social subordination was studied based on social ranks established during adulthood, and may not be synonymous with *early* life stress ([@bib111]; [@bib112], [@bib113]). Thus, when male adult cynomolgus monkeys were socially housed after previously living under individual housing procedures, a social hierarchy was formed whereby dominance rank was determined by a number of dyadic agonistic encounters, such that the first-ranking (dominant) monkey aggressed toward and usually elicited submission from all other monkeys ([@bib111]). Following the formation of these hierarchies, monkeys were tested under a fixed-ratio schedule of reinforcement, whereby 30 responses resulted in the intravenous delivery of cocaine. Under these conditions cocaine functioned as a potent reinforcer in subordinate but not dominant males, and these effects were accompanied by changes in D2 receptor availability, such that social housing increased the availability of D2 receptors in dominant monkeys which remained unchanged in subordinate monkeys. When the same effects were examined in females, the opposite effect was found ([@bib112]). Specifically, while dominant females also showed greater increases in D2 receptor availability in comparison to subordinate females, dominant females acquired cocaine reinforcement at significantly lower doses in comparison to subordinate females. These results suggest that while dominance in a social hierarchy may confer an increase in D2 receptor availability in both males and females, this increased D2 receptor availability results in differential sensitivity to the reinforcing properties of cocaine, such that subordinate males and dominant females demonstrate greater sensitivity to the reinforcing effects of cocaine in comparison to dominant males and subordinate females. These apparently conflicting data offer researchers a rare glimpse into the impact of including sex as a biological variable when examining the effects of ELS on drug self-administration. Furthermore, future research examining how social subordination *early* in life may change adolescent cocaine self-administration would provide a needed comparison to the studies mentioned above.

Recent studies have examined the potential role of subordination stress on emotional feeding as a proxy measure for dysregulated appetitive behavior ([@bib4]; [@bib38]; [@bib110]; [@bib108]). Specifically, exposure to subordinate stress in group-living females results in a greater consumption of a calorically dense diet in subordinates in comparison to dominants ([@bib4]; [@bib108]). These behavioral differences are correlated with decreases in lower D2 receptor binding potentials in the orbitofrontal cortex (oPFC) as well as lower functional connectivity between the NAc and the PFC ([@bib38]; [@bib108]). Given that these hypodopaminergic systems are evident in areas of the brain related to drug addiction, the extension of the application of NHP models of ELS to dysregulated eating may help elucidate pathological behavior and its neurobiological mechanisms, leading to the development of therapeutics that may be useful in both drug addiction as well as obesity ([@bib164]; [@bib163]).

Our group has extensively characterized the behavioral, neuroendocrine and neurobiological impact of the ELS macaque model of infant maltreatment. Importantly, studies are ongoing in our lab to examine the contribution of infant maltreatment to sensitivity to the reinforcing effects of cocaine in male and female adolescent rhesus monkeys. Combined with both the neurobiological and neuroendocrine effects previously reported by our lab, we believe these studies will further contribute to our knowledge and understanding of how ELS impacts adolescent drug use and abuse. Our laboratory is currently addressing these questions using **infant maltreatment** to investigate if this specific form of ELS leads to differential sensitivities to the reinforcing effects of cocaine during adolescence and whether increased stress/emotional reactivity resulting from infant maltreatment may mediate vulnerability to cocaine use, particularly in females.

6. Potential mechanisms linking ELS to adolescent drug abuse {#sec6}
============================================================

Despite the known risks of adolescent initiation of drug use and the development of drug dependence later in life ([@bib79]; [@bib165]), the neurobiological mechanisms underlying the increased risk during this developmental period are poorly understood. It may be the case that a combination of factors creates a perfect storm by which the adolescent brain is uniquely susceptible to both the consequences of ELS as well as the reinforcing effects of drugs. First, adolescence is a critical transition period of drastic social, emotional, endocrine, cognitive, and brain changes. These changes result in increased stress and emotional reactivity ([@bib27]; [@bib130]; [@bib128], [@bib129]; [@bib155]). Developmental changes in and between limbic and prefrontal circuits involved in stress, emotional control, and reward have been proposed to play a role in vulnerability of the adolescent brain to psychopathology ([@bib17]; [@bib20]; [@bib34]; [@bib48]). In [Fig. 1](#fig1){ref-type="fig"}, we outline a schematic that incorporates these areas of the brain, as well as multiple neurotransmitter systems involved to outline ways the brain\'s stress-response system and the mesolimbic dopaminergic pathway interact. ELS results in a hyperactive amygdala (i.e. increased stress/emotional reactivity) and HPA system (i.e. increased stress neuroendocrine reactivity), whereby cortisol released from the adrenal cortex may show impaired negative feedback to the hypothalamus and anterior pituitary, as well as extrahypothalamic structures, such as the PFC and hippocampus to shutdown secretion of cortisol. CRF is a stress neuropeptide and a critical neuromodulator of NAc DA; some CRF input to the NAc could originate in the CeA, where CRF expression has been reported to be increased as a consequence of ELS ([@bib14]). Because cortisol directly modulates DA release in the PFC, NAc, and VTA, cortisol-induced increases in DA release occurring in the NAc can increase the magnitude and duration of DA release in response to a drug reinforcer. Glutamatergic projections (from the PFC to the NAc and VTA) as well as serotonergic and GABAergic systems also serve as potent modulators of DA release throughout these major structures. The intense remodeling of the PFC characteristic during adolescence, combined with ELS-induced amygdala and HPA axis hyperreactivity (which may include impaired glucocorticoid negative feedback), and the self-administration of reinforcers that increase DA release in the NAc may create a perfect set of circumstances through which the adolescent brain becomes uniquely vulnerable to the consequences of ELS and drug abuse.Fig. 1Schematic of the dynamic neurocircuitry and neurochemistry related to ELS and adolescent drug vulnerability. In response to a stressor, CRF (green line) is secreted from the hypothalamus (gray oval), triggering the release of adrenocorticotropic hormone (ACTH; dark gray line) from the anterior pituitary (gray oval), which initiates the release of cortisol (red line) from the adrenal gland (blue oval). ELS, however, results in a hyperactive HPA system whereby cortisol may show impaired negative feedback to the hypothalamus and anterior pituitary (both gray ovals), as well as extrahypothalamic structures, such as the PFC (purple oval; part of mesolimbic DA system) and the hippocampus (red oval) to shutdown secretion of cortisol. With increases in cortisol release, DA release may also increase in other areas of the mesolimbic system, such as the NAc, and directly affect the ability of drug reinforcers to stimulate DA release. Glutamate (orange line), as well as the GABAergic and serotonergic systems (not pictured) also serve as potent modulators of DA release throughout these major structures. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1
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Similar to the effects reported in the clinical literature, in cases where ELS risk has been examined specifically in the context of drug self-administration, sensitivity to the reinforcing effects of drugs is specific to the model used, the drug in question, and the sex of the individual. However, several limitations should be discussed in light of this review. First and foremost, a general paucity of data exists regarding the biological mechanisms that may underlie ELS-increased risk for drug addiction. This lack of information is due in part to the fact that understanding the long-term risks of ELS requires an experimental design that allows researchers to characterize and quantify ELS as well as the initiation of drug use during adolescence. In many ways, the prospective/longitudinal experimental designs required to address these questions are very difficult to implement in humans, and highlights the enormous translational utility preclinical models can provide in answering these questions. This is especially true regarding NHP models, given that NHPs show a remarkable neurobiological, neuroendocrine, and socioemotional similarity to humans. However, there are very few neurodevelopmental studies in NHPs that have examined the normative and pathological neurobiological and neuroendocrine development as a function of ELS. If anything, the lack of developmental studies in NHP models of ELS to study adolescent drug use in male and female subjects represents a critical need for institutions to support NHP biomedical research.

Secondly, the analysis of sex as a biological variable is tremendously valuable especially in the context of developing novel therapeutics for the treatment of drug use. Given the enormous wealth of data demonstrating sex differences in drug use as well as in consequences of drug use (in both clinical and preclinical subjects) and ELS, the comparison of male and female subjects with regards to sensitivity to drug self-administration is necessary. This is also true for studying drug self-administration in adolescence, instead of exclusively studying these outcomes in adulthood. Because intense neurobiological, neuroendocrine, and socio-emotional changes occur both as a result of ELS and during adolescence, examining how ELS affects adolescent drug use in NHP models is of critical importance.

Thirdly, NHP studies that have characterized the effects of ELS on drug abuse outcomes have focused almost exclusively on two drugs (alcohol and cocaine). Decades of research have demonstrated that while almost all drugs of abuse produce their euphoric effects through the mesolimbic dopaminergic system, different drugs of abuse accomplish this with help from the glutamatergic, GABAergic, and brain stress neuromodulators such as CRF (for extensive reviews, see [@bib84]; [@bib87]; [@bib162]). Furthermore, most drug use is marked by polysubstance abuse and not just the use of one specific substance. Finally, it will be critical for future studies to evaluate whether or not changes in sensitivity to the reinforcing effects of drugs in one classification generalize to other drugs in the same classification. Examining the effects of ELS on drug self-administration using drug reinforcers other than alcohol and cocaine may lead to the development of novel effective therapeutics for a unique at risk population.

Although different ELS experiences likely lead to different neurobehavioral outcomes, we believe that naturalistic models such as social subordination and infant maltreatment bring unique translational value for human at-risk populations and need to be further explored. While PR and RMS offer experimenters the ability to examine how disruptions or deprivation of maternal care can result in different behavioral outcomes in comparison to healthy controls, these ELS paradigms are artificial in that the experience of the juvenile to maternal deprivation or separation would not normally happen in the wild (for a review, see [@bib62]; [@bib70]). Because of these artificial manipulations, interpretations of consequences associated with these forms of ELS can be confounded and run the risk of generalizing to human populations. Both social subordination and infant maltreatment result in species-specific adverse experiences. These experiences result in relevant developmental adaptations to the species and, therefore, are translationally valuable to human clinical conditions. Examining how ELS induces its wide array of consequences in a social environment is valuable in that ELS in humans also occurs within a social environment that shapes the individual\'s resilience or susceptibility to drug abuse. It is our belief that an ethologically valid NHP model of ELS that examines adolescent self-administration of drugs of abuse in males and females would contribute a wealth of knowledge to multiple scientific fields, and may aid in developing treatments and interventions for at risk populations.
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